Related references
Note: Only part of the references are listed.A TREM1 Variant Alters the Accumulation of Alzheimer-Related Amyloid Pathology
Joseph M. Replogle et al.
ANNALS OF NEUROLOGY (2015)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models
Taylor R. Jay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimers disease susceptibility
Towfique Raj et al.
HUMAN MOLECULAR GENETICS (2014)
Missense variant in TREML2 protects against Alzheimer's disease
Bruno A. Benitez et al.
NEUROBIOLOGY OF AGING (2014)
Upregulation of TREM2 Ameliorates Neuropathology and Rescues Spatial Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease
Teng Jiang et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Towfique Raj et al.
SCIENCE (2014)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer's Disease
Bin Zhang et al.
CELL (2013)
Overview and Findings from the Religious Orders Study
David A. Bennett et al.
Current Alzheimer Research (2013)
Overview and Findings from the Rush Memory and Aging Project
David A. Bennett et al.
Current Alzheimer Research (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Elizabeth M. Bradshaw et al.
NATURE NEUROSCIENCE (2013)
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer's Disease
Carlos Cruchaga et al.
NEURON (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS
Min-Jung Kwon et al.
NEUROBIOLOGY OF AGING (2012)
Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population
Quan Yuan et al.
NEUROLOGICAL SCIENCES (2012)
Distinct and Non-Redundant Roles of Microglia and Myeloid Subsets in Mouse Models of Alzheimer's Disease
Alexander Mildner et al.
JOURNAL OF NEUROSCIENCE (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
METAL: fast and efficient meta-analysis of genomewide association scans
Cristen J. Willer et al.
BIOINFORMATICS (2010)
The role of microglia in amyloid clearance from the AD brain
C. Y. Daniel Lee et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE
Lars Bertram et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
The TREM receptor family and signal integration
Julia Klesney-Tait et al.
NATURE IMMUNOLOGY (2006)
The Rush Memory and Aging Project: Study design and baseline characteristics of the study cohort
DA Bennett et al.
NEUROEPIDEMIOLOGY (2005)
Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling
F Lajaunias et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Share Paper
